Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:e6

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egashira, S.
Right arrow Articles by Matsumoto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egashira, S.
Right arrow Articles by Matsumoto, S.
Related Collections
Right arrow Anticoagulant mechanisms
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC

(Circulation. 1999;99:E6.)
© 1999 American Heart Association, Inc.


Circulation Electronic Pages

Case of Pulmonary Embolism

Shogo Egashira, MD, ; Yusuke Yamamoto, MD, ; Yoshitaka Doi, MD, ; Osamu Nakagaki, MD, ; Shunichi Matsumoto, MD,

From Saiseikai Fukuoka General Hospital, Department of Internal Medicine and Radiology (S.M.), Fukuoka City, Japan.

Correspondence to Shogo Egashira, MD, Department of Internal Medicine, Saiseikai Fukuoka General Hospital, 1-3-46 Tenjin, Chuou-ku, Fukuoka City 810-0001, Japan.

A65-year-old man was admitted with a pulmonary embolism. He complained of progressive exertional dyspnea followed by thrombophlebitis of his left lower limb for several weeks before admission. Venography showed multiple thrombi in the varicose left small saphenous vein. A pulmonary perfusion scintigram revealed multiple perfusion defects in both lungs; the ventilation scintigram was normal. The patient was placed on heparin 20 000 U/d IV for 7 days and urokinase 240 000 U/d IV for 4 days and was also given warfarin 2.5 mg/d PO during the same period of time.

Pulmonary helical CT (X Vision; Toshiba Medical System) was performed with 5-mm-thick sections and a 3-mm/s table increment rate. The patient received 100 mL of contrast medium (60% solution of iopamidol; Schering) at the rate of 3 mL/s with 15-second delay. Three-dimensional pulmonary CT angiography (3DCTA) was obtained by the shaded-surface-rendering method at a 1.5-mm pitch.

The 3DCTA on admission depicted clearly deformed pulmonary arterial trees (Figure 1Down), whereas the 3DCTA taken 2 weeks later demonstrated marked improvement in pulmonary arterial configuration (Figure 2Down). These findings were compatible with the patient's clinical recovery. The 3DCTA was very useful in the diagnosis and the follow-up study of pulmonary embolism.



View larger version (111K):
[in this window]
[in a new window]
 
Figure 1. 3DCTA obtained before thrombolytic therapy demonstrated that many branches of pulmonary artery were obliterated abruptly by thrombi. Top, Anterior aspect of cardiovascular system; bottom, posterior aspect.



View larger version (110K):
[in this window]
[in a new window]
 
Figure 2. Many branches of pulmonary artery could be visualized, along with abolishment of thrombi by treatment.

Footnotes

The editor of Images in . . . [Full Text of this Article]